As experts begin preparing for another season of viruses, they now know that even healthy infants with no underlying health issues are at risk for severe respiratory syncytial virus (RSV).
About 1 in 5 newborns hospitalized for surgery to treat a life-threatening bowel infection are given opioids for pain relief and some then need methadone to wean off the addictive drugs.
Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.
Screening newborns for severe combined immunodeficiency -- SCID, sometimes referred to as "bubble boy disease" -- significantly increases survival rates, researchers say.
